Quince Therapeutics, Inc. (QNCX)
1.36
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
1.33
-0.03
(-2.21%)
After-Hours: 20:00
Quince Therapeutics Total Liabilities (Quarterly) : 129.35M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 397.49M |
| Ocular Therapeutix, Inc. | 156.83M |
| Gossamer Bio, Inc. | 295.01M |
| Ernexa Therapeutics, Inc. | 3.433M |
| Acurx Pharmaceuticals, Inc. | 2.421M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 93.63M |
| Shareholders Equity (Quarterly) | -35.71M |
| Debt to Equity Ratio | -0.5172 |
| Current Ratio | 0.5297 |
| Net Debt Paydown Yield | -0.32% |